4729:9-3-08. Criteria to be considered in denying a petition for exception or removing a drug product exception


Latest version.
  • (A) The board shall consider the following factors in determining whether a particular over-the-counter (OTC) drug product containing the schedule V controlled substance ephedrine is manufactured and distributed for legitimate use in a manner consistent with the pertinent OTC tentative or final monograph issued by the United States food and drug administration and in a manner that reduces the likelihood of inappropriate use and/or abuse:

    (1) The package size and the manner of packaging;

    (2) Distribution, advertising, and promotion of the product;

    (3) Labeling and the name of the product;

    (4) The potential, duration, scope, and significance of inappropriate use and/or abuse;

    (5) Other facts as may be relevant to and consistent with public health and safety.

    (B) The board shall remove a drug product exception for a particular drug product if it determines that the drug product is not manufactured and distributed for legitimate use and in a manner that reduces the likelihood of abuse.

Replaces: 4729-12-10


Effective: 8/1/2019
Five Year Review (FYR) Dates: 08/01/2024
Promulgated Under: 119.03
Statutory Authority: 3719.28, 4729.26
Rule Amplifies: 3719.44
Prior Effective Dates: 03/13/1995, 05/24/2015